S'abonner

Epidemiology of major amputation following diabetic foot ulcer: Insights from recent nationwide data in the french national health registry (SNDS) - 22/01/25

Doi : 10.1016/j.diabet.2025.101606 
Jean-Baptiste Bonnet a, b, Claire Duflos b, c, Helena Huguet c, Antoine Avignon a, b, Ariane Sultan a, d,
a Nutrition-Diabetes Department, University Hospital of Montpellier, Montpellier, France 
b Joint Research Unit (UMR) 1302, Desbrest Institute of Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier, France 
c Clinical Research and Epidemiology Unit, CHU Montpellier, Univ Montpellier, Montpellier, France 
d PhyMedExp, INSERM U1046, National Centre for Scientific Research (CNRS) Joint Research Unit (UMR) 9214, University of Montpellier, Montpellier, France 

Corresponding author at: Nutrition-Diabetes Department, Hôpital Lapeyronie, 191 avenue du Doyen Gaston Giraud, 34295 Montpellier, France.Nutrition-Diabetes DepartmentHôpital Lapeyronie191 avenue du Doyen Gaston GiraudMontpellier34295France

Highlights

Care pathways of people with diabetic foot ulcer (DFU) and its impact on wound prognosis are poorly studied.
We found known negative prognostic factors as well as others less well explored, such as psychiatric diseases.
Inclusion in care pathways and living in less disadvantaged areas are associated with fewer major amputations.
A large number of amputations are not preceded by a hospitalization for DFU.
These results emphasize the need for multidisciplinary work through coordinated care pathways to avoid major amputations in people with DFU.

Le texte complet de cet article est disponible en PDF.

Abstract

Objective

The out-of-hospital care pathways of people with DFU have been little studied. We used the French National Health Data System (SNDS) to collect refund and care pathway data for all French residents. The aim of this study was to determine the incidence of major lower limb amputation (MA) and associated risk factors in a population with an incident DFU.

Research Design and Methods

We included any person living with diabetes and incident DFU. The primary endpoint was the occurrence of MA within one year. We considered the course and consumption of care one year before and one year after the initial event.

Results

In 2018, 133,791 people were included, and during the follow-up, MA was performed in 4,733 (3.5 %). Among these people with MAs, 16.4 % were included via the out-of-hospital part of the protocol, and their first contact with the hospital led to MA. Factors associated (hazard ratio, HR [95 % confidence interval, CI]) with MA were: being male (1.92 [1.78;2.08]), arteriopathy of the lower limb (10.16 [9.36;11.03]), psychiatric disease (1.10 [1.01;1.20]) and end-stage renal disease (2.12 [1.93;2.33]).

Regarding the care pathway, associations (HR [95 %CI]) were observed between lower MA rates and people with more general practitioner (0.83 [0.75–0.91]), private nurse (0.88 [0.81–0.95]) and diabetologist (0.88 [0.81–0.95]) visits.

Living in the most disadvantaged municipalities was associated (HR [95 %CI]) with a higher MA rate (1.17[1.06–1.29]).

Conclusion

This is the first national study of the care pathways followed by people with DFU. Failures in the care pathway, precariousness and several comorbidities were identified, with an impact on the MA risk.

Le texte complet de cet article est disponible en PDF.

Keywords : Amputation, Diabetic foot ulcer, Epidemiology, French national health data system


Plan


© 2025  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 51 - N° 2

Article 101606- mars 2025 Retour au numéro
Article précédent Article précédent
  • New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study
  • Yun Kyung Cho, Sehee Kim, Myung Jin Kim, Woo Je Lee, Ye-Jee Kim, Chang Hee Jung
| Article suivant Article suivant
  • Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis
  • Mahmoud Nassar, Hazem Abosheaishaa, Anoop Misra, Paresh Dandona, Husam Ghanim, Ajay Chaudhuri

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.